Citius Pharmaceuticals Inc (CTXR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
| 09-2014 | 06-2014 | 03-2014 | 12-2013 | 09-2013 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,552 | N/A | N/A | N/A | N/A |
| TOTAL | $1,552 | $N/A | $N/A | $N/A | $N/A |
| Non-Current Assets | |||||
| Intangibles | 5 | 0 | 0 | 0 | 0 |
| TOTAL | $5 | $N/A | $N/A | $N/A | $N/A |
| Total Assets | $1,558 | $N/A | $N/A | $N/A | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 106 | 2 | 1 | 0 | 12 |
| Accrued Expenses | 86 | 1 | 0 | N/A | 0 |
| Other current liabilities | 1,507 | N/A | N/A | N/A | N/A |
| TOTAL | $2,299 | $31 | $25 | $N/A | $15 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $2,299 | $31 | $25 | $N/A | $15 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | N/A | 48 | 48 | N/A | N/A |
| Common Shares | 30 | 18 | 18 | N/A | 18 |
| Retained earnings | -6,138 | -112 | -106 | N/A | -95 |
| TOTAL | $-742 | $-31 | $-25 | $N/A | $-15 |
| Total Liabilities And Equity | $1,558 | $0 | $0 | $0 | $0 |